Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

GLUEGLUE
16 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in MONTE ROSA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 998,253 shares of GLUE (MONTE ROSA THERAPEUTICS INC), worth $24.2M as of 2026-Q2. The position was decreased (-0.3% shares). GLUE represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$24.2M

Current Shares

998,253

Total Value Change

+$24.2M

Total Shares Change

+958,137

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
998,253
-0.3%
$24.2M0.0%$24.20
0
2026-Q1
Increased
1M
+238.5%
$16.5M0.0%$17.96
46
2025-Q4
Increased
295,878
+192.5%
$4.6M0.0%$15.97
43
2025-Q3
Decreased
101,144
-71.0%
$749,4770.0%$7.31
0
2025-Q2
Decreased
348,208
-2.2%
$1.6M0.0%$4.60
0
2025-Q1
Increased
356,112
+122.8%
$1.7M0.0%$5.10
41
2024-Q4
Decreased
159,874
-10.5%
$1.1M0.0%$7.02
0
2024-Q3
Increased
178,605
+93.4%
$946,6060.0%$5.17
40
2024-Q2
Increased
92,349
+148.4%
$345,3860.0%$3.74
38
2023-Q4
Decreased
37,178
-31.4%
$210,0560.0%$5.65
0
2023-Q3
Increased
54,210
+19.6%
$259,6660.0%$4.79
27
2023-Q2
Increased
45,336
+40.6%
$310,5520.0%$6.74
31
2023-Q1
Decreased
32,233
-26.7%
$251,0950.0%$7.36
0
2022-Q4
Increased
43,962
+32.0%
$334,5510.0%$7.61
30
2022-Q3
Decreased
33,294
-17.0%
$2720.0%$7.84
0
2022-Q2
First report
40,116
-
$3880.0%$9.79
0

Other major holders of GLUE: PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used